Back to companies

Zeria Pharmaceutical Co Ltd: Patents

View up-to-date information on Zeria Pharmaceutical Co Ltd patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4014988A1 Application NEUARTIGE BEHANDLUNG UND VORBEUGUNG EINER KRANKHEIT BASIEREND AUF EINEM IMMUNOLOGISCHEN SPEICHER A61K39/02; A61K39/04; A61K39/12; A61P35/00; G01N33/53 June 22, 2022
CA3052460C Grant A DELAYED RELEASE DRUG FORMULATION A61K31/196; A61K31/606; A61K31/616; A61K47/08; A61K47/10; A61K47/14; A61K47/32; A61K47/36; A61K47/38; A61K9/0002; A61K9/0053; A61K9/2013; A61K9/2054; A61K9/28; A61K9/284; A61K9/2846; A61K9/2853; A61K9/286; A61K9/2866; A61K9/288; A61K9/2886; A61K9/2893; A61K9/5073; A61K9/5084; A61P1/04; A61P1/10; A61P1/12; A61P31/00; A61P35/00; Y10S514/96 June 07, 2022
IL265381A Application An isolation layer for delayed drug delivery formulation, a delayed drug delivery formulation and a method for preparing such formulation A61J3/005; A61K31/606; A61K9/0053; A61K9/284; A61K9/2846; A61K9/2866; A61K9/2886; A61K9/2893; A61P1/00; A61P1/04; A61P1/10; A61P1/12; A61P29/00; A61P31/00; A61P35/00 May 01, 2022
US20220119515A1 Application TOPICAL TREATMENT OF IMMUNE CHECKPOINT INHIBITOR INDUCED DIARRHOEA, COLITIS OR ENTEROCOLITIS USING ANTIBODIES AND FRAGMENTS THEREOF A61K9/145; A61K9/1623; A61K9/5026; A61P1/14; C07K16/241 April 21, 2022
WO2022075458A1 Application NOVEL USE OF MYCOBACTERIUM TUBERCULOSIS EXTRACT A61K31/282; A61K33/243; A61K35/74; A61K39/39; A61K39/395; A61K45/00; A61P35/00; A61P35/04; A61P37/04 April 14, 2022
Discover Company Analytics for more exclusive patent trend analysis Discover Company Analytics for more exclusive patent trend analysis Get Started

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you subscribe Identify the top inventors associated with your target company when you subscribe Learn More
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer